False efficacy claims and commercial freedom of speech: What Delhi High Court held in Patanjali case

The Delhi High Court, in the Patanjali case, delved into false efficacy claims and the commercial freedom of speech. The court ruled that while commercial speech enjoys protection, it's not absolute and cannot extend to making false or misleading claims about product efficacy, especially when disparaging competitors. This decision balances freedom of expression for advertisers with consumer protection and fair competition. The court likely emphasized that exaggerated claims must be substantiated and that direct disparagement of rival products crosses legal boundaries, setting a precedent for responsible advertising in the competitive consumer goods market.